• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Cognitive behavioral therapy effective for chronic insomnia

byJeffrey CampbellandSai Folmsbee
June 9, 2015
in Chronic Disease, Psychiatry
Reading Time: 2 mins read
Decline in adolescent sleep duration over past 20 years
Share on FacebookShare on Twitter

1. From a systematic review, adults treated with cognitive behavioral therapy (CBT) for chronic insomnia experienced significant improvements in sleep onset latency, awake time, and sleep efficiency.

2. CBT was associated with marginally improved total sleep time, although not statistically significant.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Five to 15% of adults suffer from chronic insomnia, and 6 to 10% of American adults use medications to fall or stay asleep. Cognitive behavioral therapy (CBT) may provide an alternative to drug-based treatment, focusing instead on the attitudes and behaviors surrounding sleep. This study reviewed and combined data from prior trials that compared CBT with other non-drug based treatments. Insomnia was measured using self-reported changes in time to sleep onset, time spent awake after initially falling asleep, total sleep time, and sleep efficiency, defined as the total time asleep divided by total time in bed. Overall, patients who underwent CBT experienced decreased time to sleep onset and time awake after falling asleep, as well as improved sleep efficiency. Total sleep time appeared to improve only marginally, although it should be noted that CBT that includes sleep restrictions may decrease initial total sleep time. The magnitude of effect of CBT found in this study compare favorably with the magnitude of effect found in drug-based studies. However, this study excluded trials comparing CBT with drug-based insomnia therapy, so the results of this study cannot answer whether CBT is more effective than drug therapy. Nevertheless, these data suggest that CBT may have a meaningful impact on insomnia, and may be an effective alternative to other therapies.

Click to read the study, published today in the Annals of Internal Medicine

Relevant Reading: The Economic Burden of Insomnia: Direct and Indirect Costs for Individuals with Insomnia Syndrome, Insomnia Symptoms, and Good Sleepers

RELATED REPORTS

Nirsevimab (Beyfortus) may reduce severe respiratory syncytial virus infections among infants

An artificial intelligence (AI) tool achieved high diagnostic accuracy for the identification and prediction of sepsis

Use of long-acting broadly neutralizing antibodies may delay human immunodeficiency virus (HIV) rebound following discontinuation of antiretroviral therapy

In-Depth [systematic review]: This study pooled results from 19 randomized, controlled trials comparing CBT with non-pharmacologic controls for treatment of chronic insomnia. CBT was defined as ≥2 face-to-face sessions involving ≥2 of the most common CBT therapy modalities for insomnia: cognitive therapy, stimulus control, sleep restriction, sleep hygiene improvement, and relaxation therapy. Notably, studies were excluded from analysis if they tested CBT among patients with insomnia and a comorbid medical, psychiatric or sleep-related condition. Compared to control, CBT significantly decreased sleep onset latency (by 19.03 minutes, 95%CI 14.12 – 23.93 minutes), awake time after initial sleep onset (by 26.00 minutes, 95%CI 15.48 – 36.52 minutes), and sleep efficiency (by 9.91%, 95%CI 8.09% -11.73%). Total sleep time appeared to increase slightly among patients receiving CBT, although the change was not significant (by 7.61 minutes, 95%CI -0.51 – 15.74 minutes). Findings were consistent across a number of sensitivity analyses.

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Previous Post

2 Minute Medicine Rewind June 1 – June 7, 2015

Next Post

Borrelia miyamotoi disease an emerging tick-borne illness in the U.S.

RelatedReports

Emergency

Nirsevimab (Beyfortus) may reduce severe respiratory syncytial virus infections among infants

September 25, 2026
Artificial Intelligence

An artificial intelligence (AI) tool achieved high diagnostic accuracy for the identification and prediction of sepsis

September 25, 2026
Chronic Disease

Use of long-acting broadly neutralizing antibodies may delay human immunodeficiency virus (HIV) rebound following discontinuation of antiretroviral therapy

September 24, 2026
Artificial Intelligence

Large language models (LLMs) demonstrated the ability to generate accurate research manuscripts but required human oversight for more complex analyses

September 24, 2026
Next Post
Borrelia miyamotoi disease an emerging tick-borne illness in the U.S.

Borrelia miyamotoi disease an emerging tick-borne illness in the U.S.

Record-based algorithm may improve lung cancer screening follow-up

Applicants given extra time on MCAT have lower USMLE pass rates

Free alternatives comparable to Mini-Mental State Examination

Free alternatives comparable to Mini-Mental State Examination

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Nirsevimab (Beyfortus) may reduce severe respiratory syncytial virus infections among infants
  • An artificial intelligence (AI) tool achieved high diagnostic accuracy for the identification and prediction of sepsis
  • Use of long-acting broadly neutralizing antibodies may delay human immunodeficiency virus (HIV) rebound following discontinuation of antiretroviral therapy
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.